id	sid	tid	token	lemma	pos
dpc-5420	1	1	dermatology	dermatology	NOUN
dpc-5420	1	2	:	:	PUNCT
dpc-5420	1	3	practical	practical	ADJ
dpc-5420	1	4	and	and	CCONJ
dpc-5420	1	5	conceptual	conceptual	ADJ
dpc-5420	1	6	research	research	NOUN
dpc-5420	1	7	letter	letter	NOUN
dpc-5420	2	1	|	|	ADV
dpc-5420	2	2	dermatol	dermatol	ADJ
dpc-5420	2	3	pract	pract	NOUN
dpc-5420	2	4	concept	concept	NOUN
dpc-5420	2	5	.	.	PUNCT
dpc-5420	3	1	2025;15(3):5420	2025;15(3):5420	NUM
dpc-5420	3	2	1	1	NUM
dpc-5420	3	3	the	the	DET
dpc-5420	3	4	effect	effect	NOUN
dpc-5420	3	5	of	of	ADP
dpc-5420	3	6	dupilumab	dupilumab	NOUN
dpc-5420	3	7	on	on	ADP
dpc-5420	3	8	growth	growth	NOUN
dpc-5420	3	9	parameters	parameter	NOUN
dpc-5420	3	10	in	in	ADP
dpc-5420	3	11	pediatric	pediatric	ADJ
dpc-5420	3	12	atopic	atopic	NOUN
dpc-5420	3	13	dermatitis	dermatitis	NOUN
dpc-5420	3	14	patients	patient	NOUN
dpc-5420	3	15	vincenzo	vincenzo	PROPN
dpc-5420	3	16	piccolo1	piccolo1	PROPN
dpc-5420	3	17	,	,	PUNCT
dpc-5420	3	18	teresa	teresa	PROPN
dpc-5420	3	19	russo1	russo1	PROPN
dpc-5420	3	20	,	,	PUNCT
dpc-5420	3	21	julia	julia	PROPN
dpc-5420	3	22	nowowiejska2	nowowiejska2	PROPN
dpc-5420	3	23	,	,	PUNCT
dpc-5420	3	24	giuseppe	giuseppe	PROPN
dpc-5420	3	25	argenziano1	argenziano1	PROPN
dpc-5420	3	26	,	,	PUNCT
dpc-5420	3	27	carlo	carlo	PROPN
dpc-5420	3	28	mazzatenta3	mazzatenta3	PROPN
dpc-5420	3	29	,	,	PUNCT
dpc-5420	3	30	andrea	andrea	PROPN
dpc-5420	3	31	bassi3	bassi3	VERB
dpc-5420	3	32	1	1	NUM
dpc-5420	3	33	dermatology	dermatology	NOUN
dpc-5420	3	34	unit	unit	NOUN
dpc-5420	3	35	,	,	PUNCT
dpc-5420	3	36	university	university	PROPN
dpc-5420	3	37	of	of	ADP
dpc-5420	3	38	campania	campania	PROPN
dpc-5420	3	39	“	"	PUNCT
dpc-5420	3	40	luigi	luigi	PROPN
dpc-5420	3	41	vanvitelli	vanvitelli	PROPN
dpc-5420	3	42	”	"	PUNCT
dpc-5420	3	43	,	,	PUNCT
dpc-5420	3	44	naples	naples	PROPN
dpc-5420	3	45	,	,	PUNCT
dpc-5420	3	46	italy	italy	PROPN
dpc-5420	3	47	2	2	NUM
dpc-5420	3	48	department	department	NOUN
dpc-5420	3	49	of	of	ADP
dpc-5420	3	50	dermatology	dermatology	NOUN
dpc-5420	3	51	and	and	CCONJ
dpc-5420	3	52	venereology	venereology	NOUN
dpc-5420	3	53	,	,	PUNCT
dpc-5420	3	54	medical	medical	ADJ
dpc-5420	3	55	university	university	NOUN
dpc-5420	3	56	of	of	ADP
dpc-5420	3	57	bialystok	bialystok	ADJ
dpc-5420	3	58	,	,	PUNCT
dpc-5420	3	59	bialystok	bialystok	ADJ
dpc-5420	3	60	,	,	PUNCT
dpc-5420	3	61	poland	poland	PROPN
dpc-5420	3	62	3	3	NUM
dpc-5420	3	63	division	division	NOUN
dpc-5420	3	64	of	of	ADP
dpc-5420	3	65	dermatology	dermatology	NOUN
dpc-5420	3	66	,	,	PUNCT
dpc-5420	3	67	azienda	azienda	PROPN
dpc-5420	3	68	usl	usl	PROPN
dpc-5420	3	69	toscana	toscana	PROPN
dpc-5420	3	70	nord	nord	PROPN
dpc-5420	3	71	ovest	ovest	PROPN
dpc-5420	3	72	,	,	PUNCT
dpc-5420	3	73	lucca	lucca	PROPN
dpc-5420	3	74	,	,	PUNCT
dpc-5420	3	75	italy	italy	PROPN
dpc-5420	3	76	key	key	ADJ
dpc-5420	3	77	words	word	NOUN
dpc-5420	3	78	:	:	PUNCT
dpc-5420	3	79	atopic	atopic	NOUN
dpc-5420	3	80	dermatitis	dermatitis	NOUN
dpc-5420	3	81	,	,	PUNCT
dpc-5420	3	82	eczema	eczema	NOUN
dpc-5420	3	83	,	,	PUNCT
dpc-5420	3	84	dupilumab	dupilumab	NOUN
dpc-5420	3	85	,	,	PUNCT
dpc-5420	3	86	growth	growth	NOUN
dpc-5420	3	87	,	,	PUNCT
dpc-5420	3	88	height	height	NOUN
dpc-5420	3	89	citation	citation	NOUN
dpc-5420	3	90	:	:	PUNCT
dpc-5420	3	91	piccolo	piccolo	NOUN
dpc-5420	3	92	v	v	NOUN
dpc-5420	3	93	,	,	PUNCT
dpc-5420	3	94	russo	russo	PROPN
dpc-5420	3	95	t	t	PROPN
dpc-5420	3	96	,	,	PUNCT
dpc-5420	3	97	nowowiejska	nowowiejska	PROPN
dpc-5420	3	98	j	j	PROPN
dpc-5420	3	99	,	,	PUNCT
dpc-5420	3	100	et	et	PROPN
dpc-5420	3	101	al	al	PROPN
dpc-5420	3	102	.	.	PUNCT
dpc-5420	4	1	the	the	DET
dpc-5420	4	2	effect	effect	NOUN
dpc-5420	4	3	of	of	ADP
dpc-5420	4	4	dupilumab	dupilumab	NOUN
dpc-5420	4	5	on	on	ADP
dpc-5420	4	6	growth	growth	NOUN
dpc-5420	4	7	parameters	parameter	NOUN
dpc-5420	4	8	in	in	ADP
dpc-5420	4	9	pediatric	pediatric	ADJ
dpc-5420	4	10	atopic	atopic	NOUN
dpc-5420	4	11	dermatitis	dermatitis	NOUN
dpc-5420	4	12	patients	patient	NOUN
dpc-5420	4	13	.	.	PUNCT
dpc-5420	5	1	dermatol	dermatol	NOUN
dpc-5420	5	2	pract	pract	PROPN
dpc-5420	5	3	concept	concept	NOUN
dpc-5420	5	4	.	.	PUNCT
dpc-5420	6	1	2025;15(3):5420	2025;15(3):5420	X
dpc-5420	6	2	.	.	X
dpc-5420	6	3	doi	doi	PROPN
dpc-5420	6	4	:	:	PUNCT
dpc-5420	6	5	https://doi.org/10.5826/dpc.1503a5420	https://doi.org/10.5826/dpc.1503a5420	PROPN
dpc-5420	6	6	accepted	accept	VERB
dpc-5420	6	7	:	:	PUNCT
dpc-5420	6	8	april	april	PROPN
dpc-5420	6	9	31	31	NUM
dpc-5420	6	10	,	,	PUNCT
dpc-5420	6	11	2025	2025	NUM
dpc-5420	6	12	;	;	PUNCT
dpc-5420	6	13	published	publish	VERB
dpc-5420	6	14	:	:	PUNCT
dpc-5420	7	1	july	july	PROPN
dpc-5420	7	2	2025	2025	NUM
dpc-5420	7	3	copyright	copyright	NOUN
dpc-5420	7	4	:	:	PUNCT
dpc-5420	7	5	©	©	PROPN
dpc-5420	7	6	2025	2025	NUM
dpc-5420	7	7	piccolo	piccolo	NOUN
dpc-5420	7	8	et	et	PROPN
dpc-5420	7	9	al	al	PROPN
dpc-5420	7	10	.	.	PUNCT
dpc-5420	8	1	this	this	PRON
dpc-5420	8	2	is	be	AUX
dpc-5420	8	3	an	an	DET
dpc-5420	8	4	open	open	ADJ
dpc-5420	8	5	-	-	PUNCT
dpc-5420	8	6	access	access	NOUN
dpc-5420	8	7	article	article	NOUN
dpc-5420	8	8	distributed	distribute	VERB
dpc-5420	8	9	under	under	ADP
dpc-5420	8	10	the	the	DET
dpc-5420	8	11	terms	term	NOUN
dpc-5420	8	12	of	of	ADP
dpc-5420	8	13	the	the	DET
dpc-5420	8	14	creative	creative	ADJ
dpc-5420	8	15	commons	common	NOUN
dpc-5420	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5420	8	17	license	license	NOUN
dpc-5420	8	18	(	(	PUNCT
dpc-5420	8	19	by	by	ADP
dpc-5420	8	20	-	-	PUNCT
dpc-5420	8	21	nc-4.0	nc-4.0	NOUN
dpc-5420	8	22	)	)	PUNCT
dpc-5420	8	23	,	,	PUNCT
dpc-5420	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5420	8	25	,	,	PUNCT
dpc-5420	8	26	which	which	PRON
dpc-5420	8	27	permits	permit	VERB
dpc-5420	8	28	unrestricted	unrestricted	ADJ
dpc-5420	8	29	noncommercial	noncommercial	ADJ
dpc-5420	8	30	use	use	NOUN
dpc-5420	8	31	,	,	PUNCT
dpc-5420	8	32	distribution	distribution	NOUN
dpc-5420	8	33	,	,	PUNCT
dpc-5420	8	34	and	and	CCONJ
dpc-5420	8	35	reproduction	reproduction	NOUN
dpc-5420	8	36	in	in	ADP
dpc-5420	8	37	any	any	DET
dpc-5420	8	38	medium	medium	NOUN
dpc-5420	8	39	,	,	PUNCT
dpc-5420	8	40	provided	provide	VERB
dpc-5420	8	41	the	the	DET
dpc-5420	8	42	original	original	ADJ
dpc-5420	8	43	authors	author	NOUN
dpc-5420	8	44	and	and	CCONJ
dpc-5420	8	45	source	source	NOUN
dpc-5420	8	46	are	be	AUX
dpc-5420	8	47	credited	credit	VERB
dpc-5420	8	48	.	.	PUNCT
dpc-5420	9	1	funding	funding	NOUN
dpc-5420	9	2	:	:	PUNCT
dpc-5420	9	3	none	none	NOUN
dpc-5420	9	4	.	.	PUNCT
dpc-5420	10	1	competing	compete	VERB
dpc-5420	10	2	interests	interest	NOUN
dpc-5420	10	3	:	:	PUNCT
dpc-5420	10	4	none	none	NOUN
dpc-5420	10	5	.	.	PUNCT
dpc-5420	11	1	authorship	authorship	NOUN
dpc-5420	11	2	:	:	PUNCT
dpc-5420	11	3	all	all	DET
dpc-5420	11	4	authors	author	NOUN
dpc-5420	11	5	have	have	AUX
dpc-5420	11	6	contributed	contribute	VERB
dpc-5420	11	7	significantly	significantly	ADV
dpc-5420	11	8	to	to	ADP
dpc-5420	11	9	this	this	DET
dpc-5420	11	10	publication	publication	NOUN
dpc-5420	11	11	.	.	PUNCT
dpc-5420	12	1	corresponding	correspond	VERB
dpc-5420	12	2	author	author	NOUN
dpc-5420	12	3	:	:	PUNCT
dpc-5420	12	4	assist	assist	VERB
dpc-5420	12	5	.	.	PUNCT
dpc-5420	13	1	prof	prof	PROPN
dpc-5420	13	2	.	.	PROPN
dpc-5420	14	1	julia	julia	PROPN
dpc-5420	14	2	nowowiejska	nowowiejska	PROPN
dpc-5420	14	3	md	md	PROPN
dpc-5420	14	4	,	,	PUNCT
dpc-5420	14	5	phd	phd	PROPN
dpc-5420	14	6	,	,	PUNCT
dpc-5420	14	7	department	department	NOUN
dpc-5420	14	8	of	of	ADP
dpc-5420	14	9	dermatology	dermatology	NOUN
dpc-5420	14	10	and	and	CCONJ
dpc-5420	14	11	venereology	venereology	NOUN
dpc-5420	14	12	,	,	PUNCT
dpc-5420	14	13	medical	medical	ADJ
dpc-5420	14	14	university	university	NOUN
dpc-5420	14	15	of	of	ADP
dpc-5420	14	16	bialystok	bialystok	ADJ
dpc-5420	14	17	,	,	PUNCT
dpc-5420	14	18	14	14	NUM
dpc-5420	14	19	zurawia	zurawia	PROPN
dpc-5420	14	20	st	st	PROPN
dpc-5420	14	21	,	,	PUNCT
dpc-5420	14	22	15	15	NUM
dpc-5420	14	23	-	-	SYM
dpc-5420	14	24	540	540	NUM
dpc-5420	14	25	bialystok	bialystok	ADJ
dpc-5420	14	26	,	,	PUNCT
dpc-5420	14	27	poland	poland	PROPN
dpc-5420	14	28	.	.	PUNCT
dpc-5420	15	1	orcid	orcid	NOUN
dpc-5420	15	2	0000	0000	NUM
dpc-5420	15	3	-	-	PUNCT
dpc-5420	15	4	0002	0002	NUM
dpc-5420	15	5	-	-	PUNCT
dpc-5420	15	6	6870	6870	NUM
dpc-5420	15	7	-	-	PUNCT
dpc-5420	15	8	1167	1167	NUM
dpc-5420	15	9	.	.	PUNCT
dpc-5420	16	1	e	e	X
dpc-5420	16	2	-	-	NOUN
dpc-5420	16	3	mail	mail	NOUN
dpc-5420	16	4	:	:	PUNCT
dpc-5420	16	5	julia.nowowiejska@umb.edu.pl	julia.nowowiejska@umb.edu.pl	PRON
dpc-5420	16	6	introduction	introduction	NOUN
dpc-5420	16	7	no	no	DET
dpc-5420	16	8	data	datum	NOUN
dpc-5420	16	9	have	have	AUX
dpc-5420	16	10	been	be	AUX
dpc-5420	16	11	previously	previously	ADV
dpc-5420	16	12	published	publish	VERB
dpc-5420	16	13	about	about	ADP
dpc-5420	16	14	the	the	DET
dpc-5420	16	15	relationship	relationship	NOUN
dpc-5420	16	16	between	between	ADP
dpc-5420	16	17	dupilumab	dupilumab	NOUN
dpc-5420	16	18	and	and	CCONJ
dpc-5420	16	19	growth	growth	NOUN
dpc-5420	16	20	charts	chart	NOUN
dpc-5420	16	21	in	in	ADP
dpc-5420	16	22	children	child	NOUN
dpc-5420	17	1	[	[	X
dpc-5420	17	2	1	1	NUM
dpc-5420	17	3	-	-	SYM
dpc-5420	17	4	3	3	NUM
dpc-5420	17	5	]	]	PUNCT
dpc-5420	17	6	,	,	PUNCT
dpc-5420	17	7	but	but	CCONJ
dpc-5420	17	8	the	the	DET
dpc-5420	17	9	treatment	treatment	NOUN
dpc-5420	17	10	result	result	NOUN
dpc-5420	17	11	in	in	ADP
dpc-5420	17	12	our	our	PRON
dpc-5420	17	13	patient	patient	NOUN
dpc-5420	17	14	was	be	AUX
dpc-5420	17	15	so	so	ADV
dpc-5420	17	16	impressive	impressive	ADJ
dpc-5420	17	17	that	that	SCONJ
dpc-5420	17	18	we	we	PRON
dpc-5420	17	19	considered	consider	VERB
dpc-5420	17	20	it	it	PRON
dpc-5420	17	21	important	important	ADJ
dpc-5420	17	22	to	to	PART
dpc-5420	17	23	share	share	VERB
dpc-5420	17	24	it	it	PRON
dpc-5420	17	25	.	.	PUNCT
dpc-5420	18	1	case	case	NOUN
dpc-5420	18	2	presentation	presentation	NOUN
dpc-5420	18	3	the	the	DET
dpc-5420	18	4	patient	patient	NOUN
dpc-5420	18	5	was	be	AUX
dpc-5420	18	6	referred	refer	VERB
dpc-5420	18	7	to	to	ADP
dpc-5420	18	8	us	we	PRON
dpc-5420	18	9	when	when	SCONJ
dpc-5420	18	10	he	he	PRON
dpc-5420	18	11	was	be	AUX
dpc-5420	18	12	4	4	NUM
dpc-5420	18	13	years	year	NOUN
dpc-5420	18	14	old	old	ADJ
dpc-5420	18	15	,	,	PUNCT
dpc-5420	18	16	affected	affect	VERB
dpc-5420	18	17	by	by	ADP
dpc-5420	18	18	a	a	DET
dpc-5420	18	19	severe	severe	ADJ
dpc-5420	18	20	form	form	NOUN
dpc-5420	18	21	of	of	ADP
dpc-5420	18	22	atopic	atopic	NOUN
dpc-5420	18	23	dermatitis	dermatitis	NOUN
dpc-5420	18	24	(	(	PUNCT
dpc-5420	18	25	ad	ad	NOUN
dpc-5420	18	26	)	)	PUNCT
dpc-5420	18	27	,	,	PUNCT
dpc-5420	18	28	with	with	ADP
dpc-5420	18	29	easi	easi	NOUN
dpc-5420	18	30	24	24	NUM
dpc-5420	18	31	,	,	PUNCT
dpc-5420	18	32	nrs	nrs	NOUN
dpc-5420	18	33	10	10	NUM
dpc-5420	18	34	,	,	PUNCT
dpc-5420	18	35	cdlqi	cdlqi	NOUN
dpc-5420	18	36	18	18	NUM
dpc-5420	18	37	(	(	PUNCT
dpc-5420	18	38	figure	figure	NOUN
dpc-5420	18	39	1a	1a	NOUN
dpc-5420	18	40	)	)	PUNCT
dpc-5420	18	41	.	.	PUNCT
dpc-5420	19	1	the	the	DET
dpc-5420	19	2	child	child	NOUN
dpc-5420	19	3	was	be	AUX
dpc-5420	19	4	otherwise	otherwise	ADV
dpc-5420	19	5	healthy	healthy	ADJ
dpc-5420	19	6	,	,	PUNCT
dpc-5420	19	7	apart	apart	ADV
dpc-5420	19	8	from	from	ADP
dpc-5420	19	9	the	the	DET
dpc-5420	19	10	ad	ad	NOUN
dpc-5420	19	11	and	and	CCONJ
dpc-5420	19	12	the	the	DET
dpc-5420	19	13	high	high	ADJ
dpc-5420	19	14	counts	count	NOUN
dpc-5420	19	15	of	of	ADP
dpc-5420	19	16	blood	blood	NOUN
dpc-5420	19	17	eosinophils	eosinophil	NOUN
dpc-5420	19	18	and	and	CCONJ
dpc-5420	19	19	serum	serum	PROPN
dpc-5420	19	20	ige	ige	PROPN
dpc-5420	19	21	.	.	PUNCT
dpc-5420	20	1	ad	ad	PROPN
dpc-5420	20	2	had	have	AUX
dpc-5420	20	3	appeared	appear	VERB
dpc-5420	20	4	in	in	ADP
dpc-5420	20	5	the	the	DET
dpc-5420	20	6	first	first	ADJ
dpc-5420	20	7	months	month	NOUN
dpc-5420	20	8	of	of	ADP
dpc-5420	20	9	life	life	NOUN
dpc-5420	20	10	,	,	PUNCT
dpc-5420	20	11	and	and	CCONJ
dpc-5420	20	12	it	it	PRON
dpc-5420	20	13	progressively	progressively	ADV
dpc-5420	20	14	worsened	worsen	VERB
dpc-5420	20	15	with	with	ADP
dpc-5420	20	16	childhood	childhood	NOUN
dpc-5420	20	17	.	.	PUNCT
dpc-5420	21	1	at	at	ADP
dpc-5420	21	2	the	the	DET
dpc-5420	21	3	time	time	NOUN
dpc-5420	21	4	of	of	ADP
dpc-5420	21	5	consultation	consultation	NOUN
dpc-5420	21	6	,	,	PUNCT
dpc-5420	21	7	the	the	DET
dpc-5420	21	8	patient	patient	NOUN
dpc-5420	21	9	’s	’s	PART
dpc-5420	21	10	weight	weight	NOUN
dpc-5420	21	11	was	be	AUX
dpc-5420	21	12	lower	low	ADJ
dpc-5420	21	13	than	than	ADP
dpc-5420	21	14	the	the	DET
dpc-5420	21	15	3rd	3rd	ADJ
dpc-5420	21	16	percentile	percentile	NOUN
dpc-5420	21	17	,	,	PUNCT
dpc-5420	21	18	and	and	CCONJ
dpc-5420	21	19	height	height	NOUN
dpc-5420	21	20	was	be	AUX
dpc-5420	21	21	at	at	ADP
dpc-5420	21	22	the	the	DET
dpc-5420	21	23	10	10	NUM
dpc-5420	21	24	-	-	SYM
dpc-5420	21	25	25	25	NUM
dpc-5420	21	26	percentile	percentile	ADJ
dpc-5420	21	27	.	.	PUNCT
dpc-5420	22	1	the	the	DET
dpc-5420	22	2	parents	parent	NOUN
dpc-5420	22	3	were	be	AUX
dpc-5420	22	4	concerned	concerned	ADJ
dpc-5420	22	5	about	about	ADP
dpc-5420	22	6	that	that	PRON
dpc-5420	22	7	,	,	PUNCT
dpc-5420	22	8	but	but	CCONJ
dpc-5420	22	9	it	it	PRON
dpc-5420	22	10	was	be	AUX
dpc-5420	22	11	attributed	attribute	VERB
dpc-5420	22	12	to	to	ADP
dpc-5420	22	13	a	a	DET
dpc-5420	22	14	constitutional	constitutional	ADJ
dpc-5420	22	15	reason	reason	NOUN
dpc-5420	22	16	.	.	PUNCT
dpc-5420	23	1	the	the	DET
dpc-5420	23	2	patient	patient	NOUN
dpc-5420	23	3	was	be	AUX
dpc-5420	23	4	initially	initially	ADV
dpc-5420	23	5	prescribed	prescribe	VERB
dpc-5420	23	6	potent	potent	ADJ
dpc-5420	23	7	topical	topical	ADJ
dpc-5420	23	8	steroid	steroid	NOUN
dpc-5420	23	9	and	and	CCONJ
dpc-5420	23	10	topical	topical	ADJ
dpc-5420	23	11	calcineurin	calcineurin	NOUN
dpc-5420	23	12	inhibitors	inhibitor	NOUN
dpc-5420	23	13	,	,	PUNCT
dpc-5420	23	14	with	with	ADP
dpc-5420	23	15	transient	transient	ADJ
dpc-5420	23	16	,	,	PUNCT
dpc-5420	23	17	partial	partial	ADJ
dpc-5420	23	18	response	response	NOUN
dpc-5420	23	19	.	.	PUNCT
dpc-5420	24	1	at	at	ADP
dpc-5420	24	2	the	the	DET
dpc-5420	24	3	age	age	NOUN
dpc-5420	24	4	of	of	ADP
dpc-5420	24	5	five	five	NUM
dpc-5420	24	6	,	,	PUNCT
dpc-5420	24	7	the	the	DET
dpc-5420	24	8	patient	patient	NOUN
dpc-5420	24	9	was	be	AUX
dpc-5420	24	10	prescribed	prescribe	VERB
dpc-5420	24	11	oral	oral	ADJ
dpc-5420	24	12	cyclosporine	cyclosporine	NOUN
dpc-5420	24	13	(	(	PUNCT
dpc-5420	24	14	4	4	NUM
dpc-5420	24	15	mg	mg	NUM
dpc-5420	24	16	/	/	SYM
dpc-5420	24	17	kg	kg	PROPN
dpc-5420	24	18	/	/	SYM
dpc-5420	24	19	day	day	NOUN
dpc-5420	24	20	)	)	PUNCT
dpc-5420	24	21	,	,	PUNCT
dpc-5420	24	22	but	but	CCONJ
dpc-5420	24	23	the	the	DET
dpc-5420	24	24	parents	parent	NOUN
dpc-5420	24	25	refused	refuse	VERB
dpc-5420	24	26	treatment	treatment	NOUN
dpc-5420	24	27	because	because	SCONJ
dpc-5420	24	28	of	of	ADP
dpc-5420	24	29	concerns	concern	NOUN
dpc-5420	24	30	about	about	ADP
dpc-5420	24	31	side	side	NOUN
dpc-5420	24	32	effects	effect	NOUN
dpc-5420	24	33	.	.	PUNCT
dpc-5420	25	1	finally	finally	ADV
dpc-5420	25	2	,	,	PUNCT
dpc-5420	25	3	at	at	ADP
dpc-5420	25	4	the	the	DET
dpc-5420	25	5	age	age	NOUN
dpc-5420	25	6	of	of	ADP
dpc-5420	25	7	six	six	NUM
dpc-5420	25	8	,	,	PUNCT
dpc-5420	25	9	the	the	DET
dpc-5420	25	10	patient	patient	NOUN
dpc-5420	25	11	started	start	VERB
dpc-5420	25	12	treatment	treatment	NOUN
dpc-5420	25	13	with	with	ADP
dpc-5420	25	14	dupilumab	dupilumab	NOUN
dpc-5420	25	15	200	200	NUM
dpc-5420	25	16	mg	mg	PROPN
dpc-5420	25	17	,	,	PUNCT
dpc-5420	25	18	with	with	ADP
dpc-5420	25	19	a	a	DET
dpc-5420	25	20	high	high	ADJ
dpc-5420	25	21	impact	impact	NOUN
dpc-5420	25	22	on	on	ADP
dpc-5420	25	23	disease	disease	NOUN
dpc-5420	25	24	severity	severity	NOUN
dpc-5420	25	25	,	,	PUNCT
dpc-5420	25	26	itch	itch	NOUN
dpc-5420	25	27	,	,	PUNCT
dpc-5420	25	28	sleep	sleep	NOUN
dpc-5420	25	29	disturbance	disturbance	NOUN
dpc-5420	25	30	,	,	PUNCT
dpc-5420	25	31	and	and	CCONJ
dpc-5420	25	32	quality	quality	NOUN
dpc-5420	25	33	of	of	ADP
dpc-5420	25	34	life	life	NOUN
dpc-5420	25	35	(	(	PUNCT
dpc-5420	25	36	after	after	ADP
dpc-5420	25	37	48	48	NUM
dpc-5420	25	38	weeks	week	NOUN
dpc-5420	25	39	,	,	PUNCT
dpc-5420	25	40	easi	easi	NOUN
dpc-5420	25	41	2	2	NUM
dpc-5420	25	42	,	,	PUNCT
dpc-5420	25	43	nrs	nrs	NOUN
dpc-5420	25	44	1	1	NUM
dpc-5420	25	45	,	,	PUNCT
dpc-5420	25	46	cdlqi	cdlqi	NOUN
dpc-5420	25	47	1	1	NUM
dpc-5420	25	48	)	)	PUNCT
dpc-5420	25	49	(	(	PUNCT
dpc-5420	25	50	figure	figure	NOUN
dpc-5420	25	51	1b	1b	NUM
dpc-5420	25	52	)	)	PUNCT
dpc-5420	25	53	.	.	PUNCT
dpc-5420	26	1	apart	apart	ADV
dpc-5420	26	2	from	from	ADP
dpc-5420	26	3	the	the	DET
dpc-5420	26	4	expected	expect	VERB
dpc-5420	26	5	results	result	NOUN
dpc-5420	26	6	of	of	ADP
dpc-5420	26	7	the	the	DET
dpc-5420	26	8	treatment	treatment	NOUN
dpc-5420	26	9	,	,	PUNCT
dpc-5420	26	10	the	the	DET
dpc-5420	26	11	patient	patient	NOUN
dpc-5420	26	12	incredibly	incredibly	ADV
dpc-5420	26	13	started	start	VERB
dpc-5420	26	14	gaining	gain	VERB
dpc-5420	26	15	weight	weight	NOUN
dpc-5420	26	16	(	(	PUNCT
dpc-5420	26	17	10	10	NUM
dpc-5420	26	18	-	-	SYM
dpc-5420	26	19	25	25	NUM
dpc-5420	26	20	percentile	percentile	ADJ
dpc-5420	26	21	)	)	PUNCT
dpc-5420	26	22	and	and	CCONJ
dpc-5420	26	23	height	height	NOUN
dpc-5420	26	24	(	(	PUNCT
dpc-5420	26	25	25	25	NUM
dpc-5420	26	26	-	-	SYM
dpc-5420	26	27	50	50	NUM
dpc-5420	26	28	percentile	percentile	NOUN
dpc-5420	26	29	)	)	PUNCT
dpc-5420	26	30	,	,	PUNCT
dpc-5420	26	31	thus	thus	ADV
dpc-5420	26	32	appearing	appear	VERB
dpc-5420	26	33	as	as	ADV
dpc-5420	26	34	generally	generally	ADV
dpc-5420	26	35	healthy	healthy	ADJ
dpc-5420	26	36	.	.	PUNCT
dpc-5420	27	1	conclusion	conclusion	NOUN
dpc-5420	27	2	a	a	DET
dpc-5420	27	3	recent	recent	ADJ
dpc-5420	27	4	paper	paper	NOUN
dpc-5420	27	5	showed	show	VERB
dpc-5420	27	6	how	how	SCONJ
dpc-5420	27	7	a	a	DET
dpc-5420	27	8	twin	twin	NOUN
dpc-5420	27	9	affected	affect	VERB
dpc-5420	27	10	by	by	ADP
dpc-5420	27	11	ad	ad	NOUN
dpc-5420	27	12	was	be	AUX
dpc-5420	27	13	significantly	significantly	ADV
dpc-5420	27	14	shorter	short	ADJ
dpc-5420	27	15	than	than	ADP
dpc-5420	27	16	her	her	PRON
dpc-5420	27	17	healthy	healthy	ADJ
dpc-5420	27	18	sister	sister	NOUN
dpc-5420	28	1	[	[	X
dpc-5420	28	2	4	4	NUM
dpc-5420	28	3	]	]	PUNCT
dpc-5420	28	4	.	.	PUNCT
dpc-5420	29	1	a	a	DET
dpc-5420	29	2	more	more	ADV
dpc-5420	29	3	recent	recent	ADJ
dpc-5420	29	4	study	study	NOUN
dpc-5420	29	5	investigated	investigate	VERB
dpc-5420	29	6	the	the	DET
dpc-5420	29	7	impact	impact	NOUN
dpc-5420	29	8	of	of	ADP
dpc-5420	29	9	moderate	moderate	ADJ
dpc-5420	29	10	-	-	PUNCT
dpc-5420	29	11	to	to	ADP
dpc-5420	29	12	severe	severe	ADJ
dpc-5420	29	13	ad	ad	NOUN
dpc-5420	29	14	on	on	ADP
dpc-5420	29	15	growth	growth	NOUN
dpc-5420	29	16	in	in	ADP
dpc-5420	29	17	patients	patient	NOUN
dpc-5420	29	18	younger	young	ADJ
dpc-5420	29	19	than	than	ADP
dpc-5420	29	20	12	12	NUM
dpc-5420	29	21	years	year	NOUN
dpc-5420	29	22	,	,	PUNCT
dpc-5420	29	23	2	2	NUM
dpc-5420	29	24	research	research	NOUN
dpc-5420	29	25	letter	letter	NOUN
dpc-5420	29	26	|	|	ADV
dpc-5420	29	27	dermatol	dermatol	ADJ
dpc-5420	29	28	pract	pract	NOUN
dpc-5420	29	29	concept	concept	NOUN
dpc-5420	29	30	.	.	PUNCT
dpc-5420	30	1	2025;15(3):5420	2025;15(3):5420	NUM
dpc-5420	30	2	showing	show	VERB
dpc-5420	30	3	a	a	DET
dpc-5420	30	4	higher	high	ADJ
dpc-5420	30	5	mean	mean	NOUN
dpc-5420	30	6	weight	weight	NOUN
dpc-5420	30	7	and	and	CCONJ
dpc-5420	30	8	bmi	bmi	NOUN
dpc-5420	30	9	and	and	CCONJ
dpc-5420	30	10	lower	low	ADJ
dpc-5420	30	11	mean	mean	ADJ
dpc-5420	30	12	height	height	NOUN
dpc-5420	30	13	in	in	ADP
dpc-5420	30	14	ad	ad	NOUN
dpc-5420	30	15	patients	patient	NOUN
dpc-5420	30	16	than	than	ADP
dpc-5420	30	17	in	in	ADP
dpc-5420	30	18	the	the	DET
dpc-5420	30	19	reference	reference	NOUN
dpc-5420	30	20	healthy	healthy	ADJ
dpc-5420	30	21	population	population	NOUN
dpc-5420	31	1	[	[	X
dpc-5420	31	2	5	5	NUM
dpc-5420	31	3	]	]	PUNCT
dpc-5420	31	4	.	.	PUNCT
dpc-5420	32	1	different	different	ADJ
dpc-5420	32	2	explanations	explanation	NOUN
dpc-5420	32	3	may	may	AUX
dpc-5420	32	4	be	be	AUX
dpc-5420	32	5	advanced	advanced	ADJ
dpc-5420	32	6	:	:	PUNCT
dpc-5420	32	7	1	1	X
dpc-5420	32	8	.	.	X
dpc-5420	32	9	severe	severe	ADJ
dpc-5420	32	10	ad	ad	NOUN
dpc-5420	32	11	is	be	AUX
dpc-5420	32	12	definitely	definitely	ADV
dpc-5420	32	13	a	a	DET
dpc-5420	32	14	systemic	systemic	ADJ
dpc-5420	32	15	disease	disease	NOUN
dpc-5420	32	16	that	that	PRON
dpc-5420	32	17	may	may	AUX
dpc-5420	32	18	potentially	potentially	ADV
dpc-5420	32	19	affect	affect	VERB
dpc-5420	32	20	growth	growth	NOUN
dpc-5420	32	21	in	in	ADP
dpc-5420	32	22	children	child	NOUN
dpc-5420	32	23	.	.	PUNCT
dpc-5420	33	1	proper	proper	ADJ
dpc-5420	33	2	treatment	treatment	NOUN
dpc-5420	33	3	may	may	AUX
dpc-5420	33	4	interfere	interfere	VERB
dpc-5420	33	5	with	with	ADP
dpc-5420	33	6	this	this	DET
dpc-5420	33	7	effect	effect	NOUN
dpc-5420	33	8	.	.	PUNCT
dpc-5420	34	1	2	2	X
dpc-5420	34	2	.	.	X
dpc-5420	34	3	sleep	sleep	NOUN
dpc-5420	34	4	disturbance	disturbance	NOUN
dpc-5420	34	5	secondary	secondary	ADJ
dpc-5420	34	6	to	to	ADP
dpc-5420	34	7	ad	ad	NOUN
dpc-5420	34	8	could	could	AUX
dpc-5420	34	9	reduce	reduce	VERB
dpc-5420	34	10	growth	growth	NOUN
dpc-5420	34	11	hormone	hormone	NOUN
dpc-5420	34	12	(	(	PUNCT
dpc-5420	34	13	gh	gh	PROPN
dpc-5420	34	14	)	)	PUNCT
dpc-5420	34	15	production	production	NOUN
dpc-5420	34	16	and	and	CCONJ
dpc-5420	34	17	impact	impact	NOUN
dpc-5420	34	18	child	child	NOUN
dpc-5420	34	19	’s	’s	PART
dpc-5420	34	20	growth	growth	NOUN
dpc-5420	34	21	.	.	PUNCT
dpc-5420	35	1	treatment	treatment	NOUN
dpc-5420	35	2	ameliorates	ameliorate	VERB
dpc-5420	35	3	quality	quality	NOUN
dpc-5420	35	4	of	of	ADP
dpc-5420	35	5	sleep	sleep	NOUN
dpc-5420	35	6	,	,	PUNCT
dpc-5420	35	7	thus	thus	ADV
dpc-5420	35	8	impacting	impact	VERB
dpc-5420	35	9	proper	proper	ADJ
dpc-5420	35	10	production	production	NOUN
dpc-5420	35	11	of	of	ADP
dpc-5420	35	12	gh	gh	PROPN
dpc-5420	35	13	,	,	PUNCT
dpc-5420	35	14	thus	thus	ADV
dpc-5420	35	15	positively	positively	ADV
dpc-5420	35	16	impacting	impact	VERB
dpc-5420	35	17	growth	growth	NOUN
dpc-5420	35	18	.	.	PUNCT
dpc-5420	36	1	3	3	X
dpc-5420	36	2	.	.	X
dpc-5420	36	3	psychological	psychological	ADJ
dpc-5420	36	4	impact	impact	NOUN
dpc-5420	36	5	of	of	ADP
dpc-5420	36	6	ad	ad	NOUN
dpc-5420	36	7	can	can	AUX
dpc-5420	36	8	modify	modify	VERB
dpc-5420	36	9	eating	eat	VERB
dpc-5420	36	10	habits	habit	NOUN
dpc-5420	36	11	in	in	ADP
dpc-5420	36	12	children	child	NOUN
dpc-5420	36	13	,	,	PUNCT
dpc-5420	36	14	which	which	PRON
dpc-5420	36	15	may	may	AUX
dpc-5420	36	16	be	be	AUX
dpc-5420	36	17	without	without	ADP
dpc-5420	36	18	appetite	appetite	NOUN
dpc-5420	36	19	.	.	PUNCT
dpc-5420	37	1	improving	improve	VERB
dpc-5420	37	2	disease	disease	NOUN
dpc-5420	37	3	may	may	AUX
dpc-5420	37	4	be	be	AUX
dpc-5420	37	5	significant	significant	ADJ
dpc-5420	37	6	for	for	ADP
dpc-5420	37	7	a	a	DET
dpc-5420	37	8	regular	regular	ADJ
dpc-5420	37	9	and	and	CCONJ
dpc-5420	37	10	adequate	adequate	ADJ
dpc-5420	37	11	nutrition	nutrition	NOUN
dpc-5420	37	12	.	.	PUNCT
dpc-5420	38	1	4	4	X
dpc-5420	38	2	.	.	X
dpc-5420	38	3	dupilumab	dupilumab	NOUN
dpc-5420	38	4	has	have	AUX
dpc-5420	38	5	been	be	AUX
dpc-5420	38	6	associated	associate	VERB
dpc-5420	38	7	with	with	ADP
dpc-5420	38	8	a	a	DET
dpc-5420	38	9	significant	significant	ADJ
dpc-5420	38	10	activity	activity	NOUN
dpc-5420	38	11	of	of	ADP
dpc-5420	38	12	alkaline	alkaline	NOUN
dpc-5420	38	13	phosphatase	phosphatase	NOUN
dpc-5420	38	14	in	in	ADP
dpc-5420	38	15	children	child	NOUN
dpc-5420	38	16	,	,	PUNCT
dpc-5420	38	17	a	a	DET
dpc-5420	38	18	marker	marker	NOUN
dpc-5420	38	19	of	of	ADP
dpc-5420	38	20	bone	bone	NOUN
dpc-5420	38	21	mineralization	mineralization	NOUN
dpc-5420	38	22	,	,	PUNCT
dpc-5420	38	23	thus	thus	ADV
dpc-5420	38	24	meaning	mean	VERB
dpc-5420	38	25	that	that	SCONJ
dpc-5420	38	26	it	it	PRON
dpc-5420	38	27	indirectly	indirectly	ADV
dpc-5420	38	28	favors	favor	VERB
dpc-5420	38	29	growth	growth	NOUN
dpc-5420	38	30	[	[	X
dpc-5420	38	31	6	6	NUM
dpc-5420	38	32	]	]	PUNCT
dpc-5420	38	33	.	.	PUNCT
dpc-5420	39	1	all	all	DET
dpc-5420	39	2	the	the	DET
dpc-5420	39	3	above	above	ADJ
dpc-5420	39	4	reasons	reason	NOUN
dpc-5420	39	5	may	may	AUX
dpc-5420	39	6	contribute	contribute	VERB
dpc-5420	39	7	to	to	ADP
dpc-5420	39	8	the	the	DET
dpc-5420	39	9	effects	effect	NOUN
dpc-5420	39	10	of	of	ADP
dpc-5420	39	11	dupilumab	dupilumab	NOUN
dpc-5420	39	12	on	on	ADP
dpc-5420	39	13	growth	growth	NOUN
dpc-5420	39	14	charts	chart	NOUN
dpc-5420	39	15	in	in	ADP
dpc-5420	39	16	children	child	NOUN
dpc-5420	39	17	.	.	PUNCT
dpc-5420	40	1	we	we	PRON
dpc-5420	40	2	hope	hope	VERB
dpc-5420	40	3	that	that	SCONJ
dpc-5420	40	4	this	this	DET
dpc-5420	40	5	observation	observation	NOUN
dpc-5420	40	6	,	,	PUNCT
dpc-5420	40	7	although	although	SCONJ
dpc-5420	40	8	limited	limit	VERB
dpc-5420	40	9	to	to	ADP
dpc-5420	40	10	a	a	DET
dpc-5420	40	11	single	single	ADJ
dpc-5420	40	12	patient	patient	NOUN
dpc-5420	40	13	,	,	PUNCT
dpc-5420	40	14	can	can	AUX
dpc-5420	40	15	be	be	AUX
dpc-5420	40	16	a	a	DET
dpc-5420	40	17	useful	useful	ADJ
dpc-5420	40	18	spark	spark	NOUN
dpc-5420	40	19	to	to	PART
dpc-5420	40	20	induce	induce	VERB
dpc-5420	40	21	other	other	ADJ
dpc-5420	40	22	clinicians	clinician	NOUN
dpc-5420	40	23	to	to	PART
dpc-5420	40	24	investigate	investigate	VERB
dpc-5420	40	25	the	the	DET
dpc-5420	40	26	impact	impact	NOUN
dpc-5420	40	27	of	of	ADP
dpc-5420	40	28	dupilumab	dupilumab	NOUN
dpc-5420	40	29	on	on	ADP
dpc-5420	40	30	growth	growth	NOUN
dpc-5420	40	31	charts	chart	NOUN
dpc-5420	40	32	in	in	ADP
dpc-5420	40	33	children	child	NOUN
dpc-5420	40	34	,	,	PUNCT
dpc-5420	40	35	once	once	ADV
dpc-5420	40	36	again	again	ADV
dpc-5420	40	37	confirming	confirm	VERB
dpc-5420	40	38	the	the	DET
dpc-5420	40	39	importance	importance	NOUN
dpc-5420	40	40	of	of	ADP
dpc-5420	40	41	an	an	DET
dpc-5420	40	42	early	early	ADJ
dpc-5420	40	43	systemic	systemic	ADJ
dpc-5420	40	44	treatment	treatment	NOUN
dpc-5420	40	45	in	in	ADP
dpc-5420	40	46	children	child	NOUN
dpc-5420	40	47	with	with	ADP
dpc-5420	40	48	severe	severe	ADJ
dpc-5420	40	49	ad	ad	NOUN
dpc-5420	40	50	.	.	PUNCT
dpc-5420	41	1	references	reference	NOUN
dpc-5420	41	2	1	1	NUM
dpc-5420	41	3	.	.	PUNCT
dpc-5420	41	4	paller	paller	NOUN
dpc-5420	41	5	as	as	ADP
dpc-5420	41	6	,	,	PUNCT
dpc-5420	41	7	siegfried	siegfried	PROPN
dpc-5420	41	8	ec	ec	PROPN
dpc-5420	41	9	,	,	PUNCT
dpc-5420	41	10	thaçi	thaçi	PROPN
dpc-5420	41	11	d	d	PROPN
dpc-5420	41	12	,	,	PUNCT
dpc-5420	41	13	et	et	PROPN
dpc-5420	41	14	al	al	PROPN
dpc-5420	41	15	.	.	PROPN
dpc-5420	41	16	efficacy	efficacy	NOUN
dpc-5420	41	17	and	and	CCONJ
dpc-5420	41	18	safety	safety	NOUN
dpc-5420	41	19	of	of	ADP
dpc-5420	41	20	dupilumab	dupilumab	NOUN
dpc-5420	41	21	with	with	ADP
dpc-5420	41	22	concomitant	concomitant	ADJ
dpc-5420	41	23	topical	topical	ADJ
dpc-5420	41	24	corticosteroids	corticosteroid	NOUN
dpc-5420	41	25	in	in	ADP
dpc-5420	41	26	children	child	NOUN
dpc-5420	41	27	6	6	NUM
dpc-5420	41	28	to	to	PART
dpc-5420	41	29	11	11	NUM
dpc-5420	41	30	  	  	SPACE
dpc-5420	41	31	years	year	NOUN
dpc-5420	41	32	old	old	ADJ
dpc-5420	41	33	with	with	ADP
dpc-5420	41	34	severe	severe	ADJ
dpc-5420	41	35	atopic	atopic	NOUN
dpc-5420	41	36	dermatitis	dermatitis	NOUN
dpc-5420	41	37	:	:	PUNCT
dpc-5420	41	38	a	a	DET
dpc-5420	41	39	randomized	randomized	ADJ
dpc-5420	41	40	,	,	PUNCT
dpc-5420	41	41	double	double	ADJ
dpc-5420	41	42	-	-	PUNCT
dpc-5420	41	43	blinded	blind	VERB
dpc-5420	41	44	,	,	PUNCT
dpc-5420	41	45	placebo	placebo	NOUN
dpc-5420	41	46	-	-	PUNCT
dpc-5420	41	47	controlled	control	VERB
dpc-5420	41	48	phase	phase	NOUN
dpc-5420	41	49	3	3	NUM
dpc-5420	41	50	trial	trial	NOUN
dpc-5420	41	51	.	.	PUNCT
dpc-5420	42	1	j	j	PROPN
dpc-5420	42	2	am	be	AUX
dpc-5420	42	3	acad	acad	ADJ
dpc-5420	42	4	dermatol	dermatol	NOUN
dpc-5420	42	5	.	.	PUNCT
dpc-5420	43	1	2020;83(5):1282	2020;83(5):1282	PROPN
dpc-5420	43	2	-	-	SYM
dpc-5420	43	3	1293	1293	NUM
dpc-5420	43	4	.	.	PUNCT
dpc-5420	44	1	pmid	pmid	NOUN
dpc-5420	44	2	:	:	PUNCT
dpc-5420	44	3	 	 	SPACE
dpc-5420	44	4	32574587	32574587	NUM
dpc-5420	44	5	,	,	PUNCT
dpc-5420	44	6	doi	doi	NOUN
dpc-5420	44	7	:	:	PUNCT
dpc-5420	44	8	 	 	SPACE
dpc-5420	44	9	10.1016	10.1016	NUM
dpc-5420	44	10	/	/	SYM
dpc-5420	44	11	j.jaad.2020.06.054	j.jaad.2020.06.054	PROPN
dpc-5420	44	12	.	.	PUNCT
dpc-5420	45	1	2	2	X
dpc-5420	45	2	.	.	X
dpc-5420	45	3	patruno	patruno	PROPN
dpc-5420	45	4	c	c	NOUN
dpc-5420	45	5	,	,	PUNCT
dpc-5420	45	6	fabbrocini	fabbrocini	NOUN
dpc-5420	45	7	g	g	NOUN
dpc-5420	45	8	,	,	PUNCT
dpc-5420	45	9	lauletta	lauletta	VERB
dpc-5420	45	10	g	g	NOUN
dpc-5420	45	11	,	,	PUNCT
dpc-5420	45	12	et	et	PROPN
dpc-5420	45	13	al	al	PROPN
dpc-5420	45	14	.	.	PUNCT
dpc-5420	46	1	a	a	DET
dpc-5420	46	2	52	52	NUM
dpc-5420	46	3	-	-	PUNCT
dpc-5420	46	4	week	week	NOUN
dpc-5420	46	5	multicenter	multicenter	NOUN
dpc-5420	46	6	retrospective	retrospective	ADJ
dpc-5420	46	7	real	real	ADJ
dpc-5420	46	8	-	-	PUNCT
dpc-5420	46	9	world	world	NOUN
dpc-5420	46	10	study	study	NOUN
dpc-5420	46	11	on	on	ADP
dpc-5420	46	12	effectiveness	effectiveness	NOUN
dpc-5420	46	13	and	and	CCONJ
dpc-5420	46	14	safety	safety	NOUN
dpc-5420	46	15	of	of	ADP
dpc-5420	46	16	dupilumab	dupilumab	NOUN
dpc-5420	46	17	in	in	ADP
dpc-5420	46	18	children	child	NOUN
dpc-5420	46	19	with	with	ADP
dpc-5420	46	20	atopic	atopic	NOUN
dpc-5420	46	21	dermatitis	dermatitis	NOUN
dpc-5420	46	22	aged	age	VERB
dpc-5420	46	23	from	from	ADP
dpc-5420	46	24	6	6	NUM
dpc-5420	46	25	to	to	PART
dpc-5420	46	26	11	11	NUM
dpc-5420	46	27	years	year	NOUN
dpc-5420	46	28	.	.	PUNCT
dpc-5420	47	1	j	j	PROPN
dpc-5420	47	2	dermatolog	dermatolog	PROPN
dpc-5420	47	3	treat	treat	NOUN
dpc-5420	47	4	.	.	PUNCT
dpc-5420	48	1	2023;34(1):2246602	2023;34(1):2246602	NUM
dpc-5420	48	2	.	.	PUNCT
dpc-5420	49	1	pmid	pmid	NOUN
dpc-5420	49	2	:	:	PUNCT
dpc-5420	49	3	37580895	37580895	NUM
dpc-5420	49	4	doi	doi	NOUN
dpc-5420	49	5	:	:	PUNCT
dpc-5420	49	6	10.1080/09546634.2023.2246602	10.1080/09546634.2023.2246602	NUM
dpc-5420	49	7	.	.	X
dpc-5420	50	1	3	3	X
dpc-5420	50	2	.	.	X
dpc-5420	50	3	napolitano	napolitano	PROPN
dpc-5420	50	4	m	m	PROPN
dpc-5420	50	5	,	,	PUNCT
dpc-5420	50	6	fabbrocini	fabbrocini	NOUN
dpc-5420	50	7	g	g	NOUN
dpc-5420	50	8	,	,	PUNCT
dpc-5420	50	9	neri	neri	PROPN
dpc-5420	50	10	i	i	PRON
dpc-5420	50	11	,	,	PUNCT
dpc-5420	50	12	et	et	PROPN
dpc-5420	50	13	al	al	PROPN
dpc-5420	50	14	.	.	PROPN
dpc-5420	50	15	dupilumab	dupilumab	NOUN
dpc-5420	50	16	treatment	treatment	NOUN
dpc-5420	50	17	in	in	ADP
dpc-5420	50	18	children	child	NOUN
dpc-5420	50	19	aged	age	VERB
dpc-5420	50	20	6	6	NUM
dpc-5420	50	21	-	-	SYM
dpc-5420	50	22	11	11	NUM
dpc-5420	50	23	years	year	NOUN
dpc-5420	50	24	with	with	ADP
dpc-5420	50	25	atopic	atopic	NOUN
dpc-5420	50	26	dermatitis	dermatitis	NOUN
dpc-5420	50	27	:	:	PUNCT
dpc-5420	50	28	a	a	DET
dpc-5420	50	29	multicentre	multicentre	NOUN
dpc-5420	50	30	,	,	PUNCT
dpc-5420	50	31	real	real	ADJ
dpc-5420	50	32	-	-	PUNCT
dpc-5420	50	33	life	life	NOUN
dpc-5420	50	34	study	study	NOUN
dpc-5420	50	35	.	.	PUNCT
dpc-5420	51	1	paediatr	paediatr	NOUN
dpc-5420	51	2	drugs	drug	NOUN
dpc-5420	51	3	.	.	PUNCT
dpc-5420	52	1	2022;24(6	2022;24(6	NUM
dpc-5420	52	2	):	):	PUNCT
dpc-5420	52	3	671	671	NUM
dpc-5420	52	4	-	-	SYM
dpc-5420	52	5	678	678	NUM
dpc-5420	52	6	.	.	PUNCT
dpc-5420	53	1	pmid	pmid	NOUN
dpc-5420	53	2	:	:	PUNCT
dpc-5420	53	3	36028611	36028611	NUM
dpc-5420	53	4	pmcid	pmcid	NOUN
dpc-5420	53	5	:	:	PUNCT
dpc-5420	53	6	pmc9417930	pmc9417930	NOUN
dpc-5420	53	7	doi	doi	PROPN
dpc-5420	53	8	:	:	PUNCT
dpc-5420	53	9	10.1007	10.1007	NUM
dpc-5420	53	10	/s40272	/s40272	ADJ
dpc-5420	53	11	-	-	PUNCT
dpc-5420	53	12	022	022	NUM
dpc-5420	53	13	-	-	PUNCT
dpc-5420	53	14	00531	00531	NUM
dpc-5420	53	15	-	-	PUNCT
dpc-5420	53	16	0	0	NUM
dpc-5420	53	17	.	.	NOUN
dpc-5420	53	18	4	4	NUM
dpc-5420	53	19	.	.	X
dpc-5420	54	1	zhang	zhang	PROPN
dpc-5420	54	2	m	m	PROPN
dpc-5420	54	3	,	,	PUNCT
dpc-5420	54	4	he	he	PRON
dpc-5420	54	5	m	m	PROPN
dpc-5420	54	6	,	,	PUNCT
dpc-5420	54	7	tang	tang	PROPN
dpc-5420	54	8	t.	t.	VERB
dpc-5420	54	9	the	the	DET
dpc-5420	54	10	effect	effect	NOUN
dpc-5420	54	11	of	of	ADP
dpc-5420	54	12	atopic	atopic	NOUN
dpc-5420	54	13	dermatitis	dermatitis	NOUN
dpc-5420	54	14	in	in	ADP
dpc-5420	54	15	pediatric	pediatric	ADJ
dpc-5420	54	16	patients	patient	NOUN
dpc-5420	54	17	on	on	ADP
dpc-5420	54	18	height	height	NOUN
dpc-5420	54	19	:	:	PUNCT
dpc-5420	54	20	reflections	reflection	NOUN
dpc-5420	54	21	triggered	trigger	VERB
dpc-5420	54	22	by	by	ADP
dpc-5420	54	23	a	a	DET
dpc-5420	54	24	real	real	ADJ
dpc-5420	54	25	-	-	PUNCT
dpc-5420	54	26	life	life	NOUN
dpc-5420	54	27	case	case	NOUN
dpc-5420	54	28	report	report	NOUN
dpc-5420	54	29	.	.	PUNCT
dpc-5420	55	1	medicine	medicine	NOUN
dpc-5420	55	2	(	(	PUNCT
dpc-5420	55	3	baltimore	baltimore	PROPN
dpc-5420	55	4	)	)	PUNCT
dpc-5420	55	5	.	.	PUNCT
dpc-5420	56	1	2023;102(47):e36150	2023;102(47):e36150	NOUN
dpc-5420	56	2	.	.	PUNCT
dpc-5420	56	3	  	  	SPACE
dpc-5420	57	1	pmid	pmid	NOUN
dpc-5420	57	2	:	:	PUNCT
dpc-5420	57	3	38013381	38013381	NUM
dpc-5420	57	4	pmcid	pmcid	NOUN
dpc-5420	57	5	:	:	PUNCT
dpc-5420	57	6	pmc10681620	pmc10681620	PROPN
dpc-5420	57	7	doi	doi	PROPN
dpc-5420	57	8	:	:	PUNCT
dpc-5420	57	9	10.1097	10.1097	NUM
dpc-5420	57	10	/	/	SYM
dpc-5420	57	11	md.0000000000036150	md.0000000000036150	PROPN
dpc-5420	57	12	.	.	PUNCT
dpc-5420	58	1	5	5	NUM
dpc-5420	58	2	.	.	X
dpc-5420	58	3	paller	paller	NOUN
dpc-5420	58	4	as	as	ADP
dpc-5420	58	5	,	,	PUNCT
dpc-5420	58	6	geng	geng	PROPN
dpc-5420	58	7	b	b	PROPN
dpc-5420	58	8	,	,	PUNCT
dpc-5420	58	9	irvine	irvine	PROPN
dpc-5420	58	10	a	a	X
dpc-5420	58	11	,	,	PUNCT
dpc-5420	58	12	et	et	PROPN
dpc-5420	58	13	al	al	PROPN
dpc-5420	58	14	.	.	PUNCT
dpc-5420	59	1	growth	growth	NOUN
dpc-5420	59	2	analysis	analysis	NOUN
dpc-5420	59	3	in	in	ADP
dpc-5420	59	4	children	child	NOUN
dpc-5420	59	5	aged	age	VERB
dpc-5420	59	6	less	less	ADJ
dpc-5420	59	7	than	than	ADP
dpc-5420	59	8	12	12	NUM
dpc-5420	59	9	years	year	NOUN
dpc-5420	59	10	with	with	ADP
dpc-5420	59	11	moderate	moderate	ADJ
dpc-5420	59	12	-	-	PUNCT
dpc-5420	59	13	to	to	ADP
dpc-5420	59	14	-	-	PUNCT
dpc-5420	59	15	severe	severe	ADJ
dpc-5420	59	16	atopic	atopic	NOUN
dpc-5420	59	17	dermatitis	dermatitis	NOUN
dpc-5420	59	18	.	.	PUNCT
dpc-5420	60	1	paper	paper	NOUN
dpc-5420	60	2	presented	present	VERB
dpc-5420	60	3	:	:	PUNCT
dpc-5420	60	4	american	american	PROPN
dpc-5420	60	5	academy	academy	PROPN
dpc-5420	60	6	of	of	ADP
dpc-5420	60	7	dermatology	dermatology	NOUN
dpc-5420	60	8	(	(	PUNCT
dpc-5420	60	9	aad	aad	INTJ
dpc-5420	60	10	)	)	PUNCT
dpc-5420	60	11	2024	2024	NUM
dpc-5420	60	12	annual	annual	ADJ
dpc-5420	60	13	meeting	meeting	NOUN
dpc-5420	60	14	.	.	PUNCT
dpc-5420	61	1	march	march	PROPN
dpc-5420	61	2	8	8	NUM
dpc-5420	61	3	–	–	PUNCT
dpc-5420	61	4	12	12	NUM
dpc-5420	61	5	,	,	PUNCT
dpc-5420	61	6	2024	2024	NUM
dpc-5420	61	7	.	.	PUNCT
dpc-5420	62	1	san	san	PROPN
dpc-5420	62	2	diego	diego	PROPN
dpc-5420	62	3	,	,	PUNCT
dpc-5420	62	4	ca	ca	PROPN
dpc-5420	62	5	.	.	PUNCT
dpc-5420	63	1	https://aad-eposters.s3.amazonaws.com/am2024/poster/51363/	https://aad-eposters.s3.amazonaws.com/am2024/poster/51363/	PROPN
dpc-5420	63	2	growth+analysis+in+children+aged+less+than+12+years+w	growth+analysis+in+children+aged+less+than+12+years+w	PROPN
dpc-5420	63	3	ith+moderate	ith+moderate	PROPN
dpc-5420	63	4	-	-	PUNCT
dpc-5420	63	5	to	to	ADP
dpc-5420	63	6	-	-	PUNCT
dpc-5420	63	7	severe+atopic+dermatitis.pdf	severe+atopic+dermatitis.pdf	NOUN
dpc-5420	63	8	.	.	PUNCT
dpc-5420	63	9	accessed	access	VERB
dpc-5420	63	10	december	december	PROPN
dpc-5420	63	11	16	16	NUM
dpc-5420	63	12	,	,	PUNCT
dpc-5420	63	13	2024	2024	NUM
dpc-5420	63	14	.	.	PUNCT
dpc-5420	64	1	6	6	NUM
dpc-5420	64	2	.	.	X
dpc-5420	64	3	irvine	irvine	PROPN
dpc-5420	64	4	a	a	PRON
dpc-5420	64	5	,	,	PUNCT
dpc-5420	64	6	paller	paller	NOUN
dpc-5420	64	7	a	a	NOUN
dpc-5420	64	8	,	,	PUNCT
dpc-5420	64	9	horowitz	horowitz	PROPN
dpc-5420	64	10	j	j	PROPN
dpc-5420	64	11	,	,	PUNCT
dpc-5420	64	12	et	et	PROPN
dpc-5420	64	13	al	al	PROPN
dpc-5420	64	14	.	.	PROPN
dpc-5420	64	15	dupilumab	dupilumab	NOUN
dpc-5420	64	16	treatment	treatment	NOUN
dpc-5420	64	17	of	of	ADP
dpc-5420	64	18	children	child	NOUN
dpc-5420	64	19	with	with	ADP
dpc-5420	64	20	atopic	atopic	NOUN
dpc-5420	64	21	dermatitis	dermatitis	NOUN
dpc-5420	64	22	increases	increase	VERB
dpc-5420	64	23	bone	bone	NOUN
dpc-5420	64	24	alkaline	alkaline	NOUN
dpc-5420	64	25	phosphatase	phosphatase	NOUN
dpc-5420	64	26	,	,	PUNCT
dpc-5420	64	27	regardless	regardless	ADV
dpc-5420	64	28	of	of	ADP
dpc-5420	64	29	asthma	asthma	NOUN
dpc-5420	64	30	comorbidity	comorbidity	NOUN
dpc-5420	64	31	.	.	PUNCT
dpc-5420	65	1	ann	ann	PROPN
dpc-5420	65	2	allergy	allergy	PROPN
dpc-5420	65	3	,	,	PUNCT
dpc-5420	65	4	asthma	asthma	PROPN
dpc-5420	65	5	immunol	immunol	NOUN
dpc-5420	65	6	.	.	PUNCT
dpc-5420	66	1	2023	2023	NUM
dpc-5420	66	2	;	;	PUNCT
dpc-5420	66	3	131	131	NUM
dpc-5420	66	4	(	(	PUNCT
dpc-5420	66	5	5	5	NUM
dpc-5420	66	6	-	-	PUNCT
dpc-5420	66	7	suppl	suppl	ADJ
dpc-5420	66	8	1	1	NUM
dpc-5420	67	1	):	):	PUNCT
dpc-5420	67	2	s11	s11	PROPN
dpc-5420	67	3	.	.	PUNCT
dpc-5420	67	4	doi	doi	PROPN
dpc-5420	67	5	:	:	PUNCT
dpc-5420	67	6	10.1016	10.1016	NUM
dpc-5420	67	7	/	/	SYM
dpc-5420	67	8	j.anai.2023.08.048	j.anai.2023.08.048	NOUN
dpc-5420	67	9	figure	figure	NOUN
dpc-5420	67	10	1	1	NUM
dpc-5420	67	11	.	.	PUNCT
dpc-5420	68	1	(	(	PUNCT
dpc-5420	68	2	a	a	X
dpc-5420	68	3	)	)	PUNCT
dpc-5420	68	4	the	the	DET
dpc-5420	68	5	patient	patient	NOUN
dpc-5420	68	6	at	at	ADP
dpc-5420	68	7	the	the	DET
dpc-5420	68	8	age	age	NOUN
dpc-5420	68	9	of	of	ADP
dpc-5420	68	10	five	five	NUM
dpc-5420	68	11	with	with	ADP
dpc-5420	68	12	a	a	DET
dpc-5420	68	13	severe	severe	ADJ
dpc-5420	68	14	form	form	NOUN
dpc-5420	68	15	of	of	ADP
dpc-5420	68	16	atopic	atopic	NOUN
dpc-5420	68	17	dermatitis	dermatitis	NOUN
dpc-5420	68	18	(	(	PUNCT
dpc-5420	68	19	b	b	NOUN
dpc-5420	68	20	)	)	PUNCT
dpc-5420	68	21	the	the	DET
dpc-5420	68	22	same	same	ADJ
dpc-5420	68	23	patients	patient	NOUN
dpc-5420	68	24	48	48	NUM
dpc-5420	68	25	weeks	week	NOUN
dpc-5420	68	26	after	after	ADP
dpc-5420	68	27	starting	start	VERB
dpc-5420	68	28	dupilumab	dupilumab	NOUN
dpc-5420	68	29	.	.	PUNCT